Skip to main content

MoneyWorks4Me

Zydus Lifesciences submits press release

12 Apr 2025 Evaluate

Zydus Lifesciences has submitted a press release stating that Zydus received final approval from USFDA for Jaythari (Deflazacort) Tablets, 6 mg, 18 mg, 30 mg, and 36 mg.

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1905.00
Dr. Reddys Labs. 1385.00
Cipla 1406.00
Lupin 2012.00
Zydus Lifesciences 1213.05
View more..